IPTLD®

Insulin Potentiation Therapy was initially developed by my grandfather, Donato Pérez García, Sr. M.D.
IPT targets the treatment of a cell by changing the bio-physio-chemical constants and parameters of the blood. This pathway initially attacks the cancerous cell itself through its intra-cellular environment and extra-cellular environment by permeabilizing the cell membrane via insulin.

IPT is a targeted therapy for cancer and chronic disease; the power of chemotherapy is directed only to cancer cells and not a patient’s entire body. In addition, the chemo is delivered at a fraction of the normal dose. This approach eliminates or significantly reduces the dreaded side-effects of conventional chemo. IPTLD annihilates cancer cells by employing the very same mechanisms that cancer cells utilize to kill people.

IPTLD® a Registered Trademark by Donato Perez Garcia,MD
Copyright ©1930-2019 Donato Perez Garcia.



Tuesday, April 2, 2019

A brief comment on Who is Who in Insulin Potentiation Therapy (IPT or IPTLD)



The Discoverer of Insulin Potentiation Therapy was the late Donato Perez Garcia, MD (1896-1971).
Forty-eight years after his death, I am proud to represent the legacy of my grandfather and my father after him, since becoming licensed as a physician in 1983. This legacy is a unique one, with father passing along to son the gifts, wisdom, and knowledge gained only through many years of invention, triumphs, and struggle in the practice of medicine.
I seek to pass along the same hard fought wisdom, knowledge, and gifts through our Insulin Potentiation Therapy training and certification program, offered in concert with the European Academy for IPT (EAIPT). Certified IPT Practitioners who have successfully completed and maintained their education in the practice of the therapy are listed on the Academy for IPT Directory website, at: 



Donato Perez Garcia, MD

No comments:

Post a Comment